Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Paul Bolno
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
genetic medicines
oligonucleotide therapeutics |
| gptkbp:foundedYear |
2012
|
| gptkbp:founder |
Paul Bolno
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Wave Life Sciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
WVE-003
WVE-004 suvodirsen |
| gptkbp:numberOfEmployees |
200+
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:researchInterest |
neurological disorders
rare genetic diseases RNA therapeutics |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:WVE
|
| gptkbp:website |
https://www.wavelifesciences.com/
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|